Efavirenz bulk supplier for pharma manufacturers

Efavirenz Suppliers & Bulk Manufacturers

Available Forms: Tablet & Capsule

Available Strengths: Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg

Reference Brands: Sustiva®(US); Stocrin®(EU)

Efavirenz Tablets, a key NNRTI for HIV treatment, are available in 200 mg and 600 mg strengths. PharmaB2B connects global buyers with certified manufacturers offering bulk supply and fixed-dose combos like Atripla. Ideal for compliant sourcing in tenders, HIV programs, and international pharmaceutical trade.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Efavirenz Tablets are widely used as part of combination therapy for HIV-1 treatment, classified under NNRTIs. Commonly available in 600 mg and pediatric strengths, Efavirenz is also found in fixed-dose combinations like Atripla®. On PharmaB2B platforms, bulk buyers and distributors can connect with GMP-certified manufacturers for high-quality Efavirenz products. Ideal for hospitals, HIV programs, NGOs, and government tenders, PharmaB2B supports cost-effective and compliant procurement across global markets. Whether sourcing single or combo formulations, buyers benefit from reliable supply chains and competitive pricing. Choose PharmaB2B for trusted suppliers of Efavirenz and other essential antiretrovirals.

Efavirenz — third party manufacturing & bulk supply

Efavirenz is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Efavirenz is supplied as Tablet & Capsule — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Efavirenz listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Efavirenz →

Back to Listing

Frequently Asked Questions

Efavirenz is used to treat HIV-1 infection. It helps reduce viral load and improve immune function by blocking the HIV reverse transcriptase enzyme. It is typically used as part of combination antiretroviral therapy.

Efavirenz is made from the active non-nucleoside reverse transcriptase inhibitor (NNRTI) compound efavirenz, a synthetic benzoxazinone derivative.

The well-known trade name is Sustiva.

Sustiva is manufactured by Bristol-Myers Squibb (BMS). Many generic pharmaceutical companies worldwide also produce efavirenz.

The generic name is efavirenz.

The primary brand name is Sustiva.

Efavirenz is manufactured in approved facilities across the USA, Europe, and India, depending on whether it is the innovator brand or a generic version.